NLRP3 plays an important role in the progression of metabolic disorders, including obesity-induced insulin resistance and the development and severity of gout, nonalcoholic fatty liver disease, and type 2 diabetes [4]. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.